COPD肺泡巨噬细胞S1PR5 DNA甲基化降低与胞葬功能缺陷相关
本研究探讨COPD患者肺泡巨噬细胞中S1P系统相关基因的DNA甲基化改变及其与胞葬功能缺陷的关系。采用亚硫酸氢盐测序和甲基化定量PCR检测20例COPD患者、7例健康吸烟者和10例健康非/戒烟者肺泡巨噬细胞的甲基化水平。结果显示COPD患者S1PR5甲基化降低,体外去甲基化可增强THP-1巨噬细胞胞葬能力并逆转吸烟诱导的缺陷。
要点
- COPD患者肺泡巨噬细胞S1PR5 DNA甲基化水平低于非/戒烟者。
- 5-氮杂胞苷去甲基化可剂量依赖性逆转香烟烟雾诱导的胞葬缺陷。
- S1PR5甲基化降低可能是COPD胞葬功能缺陷的表观遗传机制。
核心结论
- 巨噬细胞功能可受表观遗传调控,S1PR5甲基化降低可能解释COPD肺泡巨噬细胞S1PR5表达升高及胞葬功能缺陷。
研究设计与样本
- 采用亚硫酸氢盐测序和甲基化定量实时PCR检测肺泡巨噬细胞中SPHK1、S1PR1和S1PR5相关CpG岛甲基化水平。
- 样本包括20例COPD患者、7例健康吸烟者和10例健康非/戒烟者的肺泡巨噬细胞。
- 体外使用DNA甲基转移酶抑制剂5-氮杂胞苷处理THP-1巨噬细胞,流式细胞术评估胞葬能力。
主要发现
- 在所检测的S1P系统基因中,S1PR5是唯一在患者组间DNA甲基化存在显著差异的基因。
- COPD患者肺泡巨噬细胞在相同区域甲基化水平低于非/戒烟者。
- 5-氮杂胞苷去甲基化增加THP-1巨噬细胞胞葬能力,并剂量依赖性逆转香烟烟雾诱导的胞葬缺陷。
临床怎么用
- S1PR5甲基化状态可能作为评估COPD肺泡巨噬细胞胞葬功能的表观遗传标志物。
- 表观遗传调控(如去甲基化)可能是改善COPD巨噬细胞胞葬缺陷的潜在干预方向。
局限性
- 样本量较小(COPD 20例、健康吸烟者7例、健康非/戒烟者10例)。
- 体外实验使用THP-1细胞系,不能完全代表原代肺泡巨噬细胞。
- 未明确DNA甲基化直接调控巨噬细胞功能的具体因果机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: We previously showed that alveolar macrophages from COPD patients are defective in their ability to phagocytose apoptotic cells ('efferocytosis') and that this defect is potentially linked to the sphingosine-1 phosphate (S1P) system, in particular the sphingosine-1 phosphate receptor 5 (S1PR5). In alveolar macrophages from COPD patients, S1PR5 mRNA expression levels increased and were correlated with both lung function and efferocytosis. However, it us unknown whether these changes are under epigenetic control via DNA methylation or whether DNA methylation directly modulates macrophage function. METHODS: Bisulfite sequencing was used to assess DNA methylation levels at CpG islands associated with genes encoding selected S1P system components, including sphingosine kinase 1 (SPHK1), S1PR1 and S1PR5, in alveolar macrophages from 20 COPD patients, 7 healthy smokers and 10 healthy non/ex-smokers) by methyl quantitative real-time PCR (methyl qPCR). The effect of the DNA methyltransferase inhibitor, 5-azacytidine on the efferocytosis capacity of THP-1 macrophages was assessed using flow cytometry. RESULTS: Among the S1P system genes examined, S1PR5 was the single target that showed significant changes in DNA methylation between patient groups. Alveolar macrophages isolated from COPD patients showed lower methylation levels in the same region compared to macrophages from non/ex-smokers. in vitro studies using THP-1 macrophages showed that DNA demethylation with 5-azacytidine increased the efferocytosis capacity and dose-dependently rescued the cells from the cigarette smoke-induced defect in efferocytosis. CONCLUSION: Macrophage function can be modulated epigenetically. Reduced methylation may underlie the increased expression of the S1PR5 gene in alveolar macrophages and associated defective efferocytosis in COPD.
引用
- Barnawi J, Jersmann H, Haberberger R, et al. Reduced DNA methylation of sphingosine-1 phosphate receptor 5 in alveolar macrophages in COPD: A potential link to failed efferocytosis. Respirology. 2016. PMID: 27868302. doi:10.1111/resp.12949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。